Diclofenac diethylamine

Drug Profile

Diclofenac diethylamine

Alternative Names: Z-7202

Latest Information Update: 21 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Zambon SpA
  • Class Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Acute pain; Musculoskeletal pain

Most Recent Events

  • 21 Apr 2015 No recent reports of development identified - Phase-III for Acute pain in Hungary, Lithuania and Estonia (Topical)
  • 07 Sep 2012 Zambon completes a phase III trial in Musculoskeletal pain in Estonia and Lithuania (EudraCT2011-000725-69)
  • 09 Dec 2011 Zambon completes a phase III trial in post-traumatic pain in Hungary (EudraCT2010-022736-37)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top